Vitamin K: A potential Liver Cancer treatment way

Sofia Dahlberg, Ulf Schött

Forskningsoutput: TidskriftsbidragÖversiktsartikelPeer review

Sammanfattning

A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K dependent coagulation factor II, with the commercial ELISA test PIVKA-II has been used as a hepatocellular cancer marker. Its relevance is also reviewed. Currently the PIVKA-II test has been withdrawn due to marketing reasons by Stago
Originalspråkengelska
Sidor (från-till)049-052
TidskriftArchives of Hepatitis Research
Volym3
Nummer2
DOI
StatusPublished - 2017

Ämnesklassifikation (UKÄ)

  • Cancer och onkologi

Fingeravtryck

Utforska forskningsämnen för ”Vitamin K: A potential Liver Cancer treatment way”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här